These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8583558)

  • 21. [A double-blind trial on the effect of alpha-adrenergic blocker (bunazosin hydrochloride) in the symptomatic treatment of prostatism].
    Kumamoto Y; Yokoyama E; Tsukamoto T; Tsuchida S; Nishizawa O; Koshiba K; Ishibashi A; Ogawa A; Tomita Y; Aso Y
    Hinyokika Kiyo; 1987 Oct; 33(10):1681-702. PubMed ID: 2451409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficiency and tolerance of terazosine in ambulatory patients with benign prostatic hypertrophy: comparative randomized and double-blind trial versus alfuzosin. The MG Terazosine Group].
    Fourcade RO
    Prog Urol; 2000 Apr; 10(2):246-53. PubMed ID: 10857142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome.
    Cheah PY; Liong ML; Yuen KH; Teh CL; Khor T; Yang JR; Yap HW; Krieger JN
    Urology; 2004 Nov; 64(5):881-6. PubMed ID: 15533470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of selective alpha-1 blocker therapy in the treatment of acute urinary symptoms during radiotherapy for localized prostate cancer.
    Zelefsky MJ; Ginor RX; Fuks Z; Leibel SA
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):567-70. PubMed ID: 10524407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Terazosin for BPH.
    Jerant AF
    J Fam Pract; 1995 Mar; 40(3):222-3. PubMed ID: 7533204
    [No Abstract]   [Full Text] [Related]  

  • 26. [Patterns of use of terazosine in current medical practice in ambulatory patients with obstructive and irritative obstructive disorders of urination].
    Serment G; Rossi D; Reitz C; Boumendil O
    Prog Urol; 2000 Apr; 10(2):254-60. PubMed ID: 10857143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Terazosin in mild hypertension: experience in open trials.
    Rosenthal J
    Br J Clin Pract Suppl; 1987 Dec; 54():32-44. PubMed ID: 2905160
    [No Abstract]   [Full Text] [Related]  

  • 28. [Efficacy of setegis administration after transvesical adenomectomy].
    Gorilovskiĭ LM; Zingerenko MB; Lakhno DA
    Urologiia; 2007; (6):61, 63-5. PubMed ID: 18649663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical experience: symptomatic management of BPH with terazosin.
    Dunzendorfer U
    Urology; 1988 Dec; 32(6 Suppl):27-31. PubMed ID: 2462302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The medication minute: terazosin.
    Bartek JK; McNamee M
    Urol Nurs; 1995 Jun; 15(2):67-8. PubMed ID: 7541161
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of terazosin in the treatment of benign prostatic hyperplasia. A pilot study.
    Dunzendorfer U
    Arzneimittelforschung; 1989 Oct; 39(10):1289-91. PubMed ID: 2482025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of postherniorrhaphy urinary retention with prazosin.
    Gönüllü NN; Dülger M; Utkan NZ; Cantürk NZ; Alponat A
    Am Surg; 1999 Jan; 65(1):55-8. PubMed ID: 9915533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of idiopathic oligozoospermia with an alpha-blocker: a placebo-controlled double-blind trial.
    Gregoriou O; Vitoratos N; Papadias C; Gargaropoulos A; Konidaris S; Giannopoulos V; Chryssicopoulos A
    Int J Fertil Womens Med; 1997; 42(5):301-5. PubMed ID: 9406835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of terazosin on prostatism in men with normal and abnormal peak urinary flow rates.
    Lepor H; Nieder A; Feser J; O'Connell C; Dixon C
    Urology; 1997 Mar; 49(3):476-80. PubMed ID: 9123722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study.
    Yang Y; Zhao XF; Li HZ; Wang W; Zhang Y; Xiao H; Zhang X
    Chin Med J (Engl); 2007 Mar; 120(5):370-4. PubMed ID: 17376305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial.
    Cheah PY; Liong ML; Yuen KH; Teh CL; Khor T; Yang JR; Yap HW; Krieger JN
    J Urol; 2003 Feb; 169(2):592-6. PubMed ID: 12544314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multicenter, double-blind, placebo-controlled trial of the efficacy of prazosin in the treatment of dysuria associated with benign prostatic hypertrophy.
    Le Duc A; Cariou G; Baron C; Cukier J; Quentel P; Faure G; Rambeaud JJ; Navratil H; Costa P; Richaud JJ
    Urol Int; 1990; 45 Suppl 1():56-62. PubMed ID: 1690483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical applications of alpha 1-receptor blockade: terazosin in the management of hypertension. Introduction.
    Rosenthal J; Kyncl JJ
    J Clin Pharmacol; 1993 Sep; 33(9):866-7. PubMed ID: 7901240
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of sympathetically maintained pain with terazosin.
    Stevens DS; Robins VF; Price HM
    Reg Anesth; 1993; 18(5):318-21. PubMed ID: 7903550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of terazosin on functional bladder outlet obstruction in women: a pilot study.
    Kessler TM; Studer UE; Burkhard FC
    J Urol; 2006 Oct; 176(4 Pt 1):1487-92. PubMed ID: 16952666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.